Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-337-7 | CAS number: 13308-51-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Genetic toxicity in vitro: Gene mutation (Bacterial reverse mutation assay / Ames test, OECD 471): S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvr A: negative with and without metabolic activation
Mammalian cytogenicity (Micronucleus test, OECD 487): Chinese hamster lung fibroblasts (V79): negative with and without metabolic activation
Mammalian mutagenicity (Mouse lymphoma gene mutation assay, OECD 476): Mouse lymphoma L5178Y cells: negative with and without metabolic activation
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 Feb - 01 Jun 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (1997)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his/trp operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Preliminary toxicity test:
- 156, 313, 625, 1250, 2500 and 5000 µg/plate (TA 98 and TA 1535 with and without metabolic activation)
Experiment I+II:
- 313, 625, 1250, 2500 and 5000 µg/plate (with and without metabolic activation) - Vehicle / solvent:
- - Vehicle/solvent used: distilled water
- Justification for choice of solvent: Distilled water was used as solvent, since this medium is not suspected of chemical reaction with the test substance and is compatible with the survival of the bacteria and the S9 activity. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9-mix: daunomycin (DM), sodium azide (NaN), ICR 191 acridine (ICR), 4-nitroquinoline-1-oxide (4-NQO); +S9-mix: 2-aminoanthracene (2-AA), benzo(a)pyrene (BaP)
- Remarks:
- DM (6 µg/plate: TA 98); NaN (1.5 µg/plate: TA 100, TA 1535); ICR (1 µg/plate: TA 1537); 4-NQO (2 µg/plate: E.coli WP2 uvrA); 2-AA (10 µg/plate: TA 98, TA 100, TA 1535, TA 1537; 50 µg/plate: E.coli WP2 uvrA); BaP (20 µg/plate: TA 98, TA 100)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: 3 plates for each test concentration and control
DETERMINATION OF CYTOTOXICITY
- A preliminary experiment was conducted with the test material in tester strains TA 98 and TA 1535 either in the presence or in the absence of metabolic activation to determine cytotoxicity and solubility of the test substance using concentrations of 156, 313, 625, 1250, 2500 and 5000 µg/plate.
- Method: Cytotoxicity is detected by reduction in the number of revertant colonies - Evaluation criteria:
- Means of individual plate counts (triplicates) were calculated for test solutions and controls. In general, a 2 or 2.5-fold increase in the number of revertant colonies per plate over the background (spontaneous revertant frequency) is used as a criterion to distinguish active mutagens from non-mutagenic materials. The presence of dose-response is a further criterion for mutagenic materials.
- Statistics:
- Mean values and standard deviation were calculated for each test and control concentration.
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Slight precipitations were seen in all test material concentrations which did not influence the results of the assay.
RANGE-FINDING/SCREENING STUDIES
As no relevant cytotoxicity was observed in the preliminary test (data not shown), the highest test concentration used in the main test was 5000 µg/plate.
ADDITIONAL INFORMATION ON CYTOTOXICITY
No signs of cytotoxicity are reported.
COMPARISON WITH HISTORICAL CONTROL DATA
The colony counts of negative and positive controls were in the dimensions of historical and literature data. - Conclusions:
- Interpretation of results: negative
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 Feb - 02 Jun 2015
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: OECD Guideline 487 (In Vitro Mammalian Cell Micronucleus Test (2014)
- Deviations:
- yes
- Remarks:
- No cytotoxicity was determined either in a preliminary cytotoxicity test or within the main experiments, thus dose selection for the main experiment is questionable
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell micronucleus test
- Target gene:
- Not applicable
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
RPMI 1640 medium supplemented with
- 10% (v/v) fetal bovine serum (FBS)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Preliminary range-finding solubility test:
- 0.32, 1.6, 8, 40, 200 and 1000 µg/mL (4 and 24 h)
Main experiment:
- 0.178, 0.53 and 1.6 µg/mL (4 h exposure with and without metabolic activation)
- 0.178, 0.53 and 1.6 µg/mL (24 h exposure without metabolic activation) - Vehicle / solvent:
- - Vehicle/solvent used: RPMI 1640 medium supplemented with 10% (v/v) FBS
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9-mix: 0.2 µg/mL colchicine; +S9-mix: 5 µg/mL benzo(a)pyrene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 and 24 h
- Fixation time (start of exposure up to fixation or harvest of cells): 4 h treatment: 24 h (1.5-2.0 normal cell cycles); 24 h treatment: 24 h (1.5-2.0 normal cell cycles)
STAIN: Hoechst 33258 solution and Pyronin Y
NUMBER OF REPLICATIONS: duplicate cultures for each test concentration and control
NUMBER OF CELLS EVALUATED: at least 2000 binucleated cells per concentration
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth (relative increase in cell counts, RICC); cytotoxicity = 100% - RICC [%] - Evaluation criteria:
- A test substance was classified as genotoxic, if at least a 3-fold increased number of micronuclei in relation to the negative control was counted and/or a dose-response relationship was observed.
- Statistics:
- Mean values were calculated for each test and control culture.
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: at the highest test concentration of 1.6 µg/mL 19.8% cytotoxicity was determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Because of the solubility as a limiting factor, 1.6 µg/mL was chosen as the maximum concentration. This concentration was the highest concentration at which minimal precipitate was visible by light microscopy.
RANGE-FINDING/SCREENING STUDIES
Prior to testing of solved sample material, a preliminary range-finding test for the maximal concentration was done because the test material was a slightly soluble inorganic salt. Concentrations of 0.32, 1.6, 8, 40, 200 and 1000 µg/mL were prepared and incubated at 37 ± 1 °C under moderate agitation at the same time for approximately 4 and 24 h. The estimation of particles was done by gravimetric sedimentation followed by a microscopically examination. The highest concentration was the solution with no or a minimal precipitate content in the cultures, thus 1.6 µg/mL was selected as the highest test concentration.
ADDITIONAL INFORMATION ON CYTOTOXICITY
Slight cytotoxicity (19.8%) was only recorded at the highest test concentration of 1.6 µg/ml.. - Conclusions:
- Interpretation of results: negative
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07 Jan - 03 Mar 2015
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- (1997)
- Deviations:
- yes
- Remarks:
- No cytotoxicity was determined within the main experiments. No vehicle controls were used in a preliminary cytotoxicity tests, thus dose selection for the main experiment is questionable.
- GLP compliance:
- yes
- Type of assay:
- other: mammalian cell gene mutation assay
- Target gene:
- TK locus
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
RPMI 1640 medium supplemented with
- 10% (v/v) heat inactivated horse serum (cultivation and exposure medium)
- 20% (v/v) heat inactivated horse serum (cloning and mutant selection medium) - Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Preliminary range-finding test I+II:
- 0.32, 1.6, 8, 40, 200, 1000 and 5000 µg/mL (with and without metabolic activation)
- 125, 250, 500, 1000 and 2000 µg/mL (with and without metabolic activation)
Main and Confirmatory test:
- 31.25, 62.5, 125 and 250 µg/mL (with and without metabolic activation) - Vehicle / solvent:
- - Vehicle/solvent used: RPMI 1640 medium supplemented with 10% (v/v) heat inactivated horse serum
- Justification for choice of solvent/vehicle: RPMI 1640 cell culture medium was used as vehicle/solvent, since this medium is not suspected of chemical reaction with the test substance and is compatible with the survival of the cells and the S9 activity. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- methylmethanesulfonate
- Remarks:
- Methylmethanesulfonate (10 µg/mL, -S9-mix); Benzo(a)pyrene (1.5 µg/mL, +S9-mix)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension
DURATION
- Exposure duration: 3 h
- Expression time (cells in growth medium): 2 days after the end of the treatment, cells were plated for determination of the cloning efficiency and the mutation frequency in 96-well microtitre plates containing TFT selective medium. The microtitre plates were incubated for 7 days (cloning efficiency) or 11 - 14 days (mutation frequency).
- Selection time: 11 - 14 days
SELECTION AGENT: 3 µg/mL trifluorothymidine (TFT)
NUMBER OF REPLICATIONS: duplicate cultures for each test concentration and the negative control, single culture for the positive control
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- The cloning efficiency (CE) of cells and the spontaneous mutation frequency (MF) of negative controls should be within their limit values (CE ≥50%; MF (negative control) 50 - 300 x 1E-06). The MF of positive controls should be increased 2 times or more than the MF in corresponding negative controls in each experiment. The results of negative and positive controls will confirm the sensitivity and accuracy of the test system according to the criteria of acceptance of literature and SOP.
- Statistics:
- No statistics were performed since only cloning efficiency and mutation frequency were calculated.
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: The pH during the exposure of the cells to the test substance did not change (colour of the pH indicator in the culture medium).
- Precipitation: Slight precipitations were seen in all test material concentrations which did not influence the results of the assay.
RANGE-FINDING/SCREENING STUDIES
Preliminary experiments were conducted (with and without metabolic activation) at concentrations of 0.32, 1.6, 8, 40, 200, 1000 and 5000 µg/mL (test I) and 125, 250, 500, 1000 and 2000 µg/mL (test II) to determine cytotoxicity and solubility of the test material. A concentration of 250 µg/mL was chosen as the highest concentration for the main and confirmatory experiment based on cytotoxicity (44/45% for CE 1 and 13/0% for CE 2 (with/without S9-mix)) and precipitation.
COMPARISON WITH HISTORICAL CONTROL DATA
The observed cloning efficiency (CE 1 and CE 2) and the mutation frequency (MF) were in the range of historical control data.
ADDITIONAL INFORMATION ON CYTOTOXICITY
In all test concentrations, negative and positive controls either both in the presence and absence of metabolic activation (1% (v/v) S9-mix) the cloning efficiency (CE 1 and CE 2) was not significantly different compared to the vehicle control group. No relevant cytotoxicity was determined within the experiments. - Conclusions:
- Interpretation of results: negative
Referenceopen allclose all
Table 1: Test results - Experiment I - Preincubation method
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||
– |
0 |
79 ± 2 |
8 ± 0 |
13 ± 2 |
13 ± 4 |
8 ± 2 |
– |
313 |
87 ± 7 |
11 ± 2 |
10 ± 2 |
12 ± 1 |
6 ± 1 |
– |
625 |
69 ± 8 |
8 ± 2 |
13 ± 6 |
11 ± 4 |
6 ± 3 |
– |
1250 |
74 ± 6 |
7 ± 3 |
15 ± 2 |
11 ± 4 |
3 ± 1 |
– |
2500 |
89 ± 13 |
7 ± 5 |
11 ± 3 |
12 ± 5 |
4 ± 2 |
– |
5000 |
85 ± 8 |
8 ± 1 |
11 ± 4 |
15 ± 6 |
7 ± 3 |
Positive controls, –S9 |
Name |
NaN |
NaN |
4-NQO |
DM |
ICR |
Concentrations (μg/plate) |
1.5 |
1.5 |
2 |
6 |
1 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
499 ± 31 |
431 ± 26 |
839 ± 67 |
435 ± 95 |
2040 ± 59 |
|
+ |
0 |
68 ± 11 |
7 ± 2 |
10 ± 5 |
13 ± 3 |
4 ± 1 |
+ |
313 |
63 ± 6 |
6 ± 0 |
12 ± 2 |
17 ± 3 |
6 ± 1 |
+ |
625 |
59 ± 16 |
7 ± 1 |
12 ± 4 |
18 ± 4 |
4 ± 2 |
+ |
1250 |
68 ± 20 |
8 ± 4 |
11 ± 2 |
20 ± 5 |
5 ± 3 |
+ |
2500 |
70 ± 15 |
6 ± 2 |
11 ± 6 |
16 ± 2 |
4 ± 2 |
+ |
5000 |
72 ± 10 |
6 ± 4 |
10 ± 3 |
18 ± 2 |
4 ± 2 |
Positive controls, +S9 (10%) |
Name |
2-AA / BaP |
2-AA |
2-AA |
2-AA / BaP |
2-AA |
Concentrations (μg/plate) |
10 / 20 |
10 |
50 |
10 / 20 |
10 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
1807 ± 11 / 584 ± 19 |
56 ± 7 |
316 ± 62 |
2068 ± 60 / 290 ± 79 |
182 ± 25 |
DM: daunomycin
NaN: sodium azide
ICR: ICR 191 acridine
4-NQO: 4-nitroquinoline-1-oxide
2-AA: 2-aminoanthracene
BaP: benzo(a)pyrene
Table 2: Test results - Experiment II - Plate incorporation method
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||
– |
0 |
70 ± 12 |
8 ± 3 |
10 ± 5 |
29 ± 4 |
4 ± 1 |
– |
313 |
81 ± 6 |
6 ± 3 |
12 ± 6 |
18 ± 8 |
4 ± 3 |
– |
625 |
88 ± 13 |
8 ± 3 |
11 ± 1 |
17 ± 3 |
5 ± 1 |
– |
1250 |
81 ± 9 |
7 ± 2 |
13 ± 2 |
10 ± 3 |
6 ± 1 |
– |
2500 |
97 ± 12 |
6 ± 3 |
12 ± 3 |
17 ± 5 |
5 ± 2 |
– |
5000 |
79 ± 7 |
6 ± 3 |
14 ± 2 |
16 ± 4 |
4 ± 2 |
Positive controls, –S9 |
Name |
NaN |
NaN |
4-NQO |
DM |
ICR |
Concentrations (μg/plate) |
1.5 |
1.5 |
2 |
6 |
1 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
468 ± 37 |
385 ± 12 |
1185 ± 291 |
576 ± 99 |
82 ± 13 |
|
+ |
0 |
86 ± 12 |
4 ± 0 |
12 ± 6 |
12 ± 4 |
5 ± 2 |
+ |
313 |
72 ± 3 |
6 ± 3 |
12 ± 5 |
11 ± 6 |
4 ± 1 |
+ |
625 |
77 ± 4 |
7 ± 2 |
8 ± 3 |
22 ± 8 |
5 ± 2 |
+ |
1250 |
73 ± 10 |
5 ± 2 |
11 ± 2 |
19 ± 3 |
5 ± 1 |
+ |
2500 |
73 ± 16 |
7 ± 3 |
13 ± 2 |
14 ± 3 |
4 ± 2 |
+ |
5000 |
70 ± 5 |
5 ± 2 |
14 ± 1 |
12 ± 7 |
4 ± 2 |
Positive controls, +S9 (10%) |
Name |
2-AA / BaP |
2-AA |
2-AA |
2-AA / BaP |
2-AA |
Concentrations (μg/plate) |
10 / 20 |
10 |
50 |
10 / 20 |
10 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
856 ± 154 / 383 ± 9 |
45 ± 2 |
378 ± 48 |
1782 ± 201 / 136 ± 23 |
175 ± 49 |
DM: daunomycin
NaN: sodium azide
ICR: ICR 191 acridine
4-NQO: 4-nitroquinoline-1-oxide
2-AA: 2-aminoanthracene
BaP: benzo(a)pyrene
Table 3: Historical control data (negative control)
Strain |
MIN |
MAX |
MEAN |
SD |
N |
|||||
|
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
TA 98 |
13 |
21 |
54 |
65 |
29 |
38 |
16 |
19 |
5 |
5 |
TA 100 |
62 |
63 |
246 |
232 |
112 |
108 |
78 |
70 |
5 |
5 |
TA 1535 |
7 |
8 |
28 |
20 |
14 |
11 |
8 |
5 |
5 |
5 |
TA 1537 |
3 |
3 |
4 |
6 |
4 |
5 |
n.a. |
n.a. |
2 |
2 |
WP2 uvrA |
13 |
13 |
17 |
20 |
15 |
18 |
2 |
3 |
4 |
4 |
SD: standard deviation
n.a.: not applicable
N: number of studies
Table 4: Historical control data (positive control)
Strain |
Chemical |
MIN |
MAX |
N |
TA 98 |
2-Aminoanthracene |
135 |
>1000 |
5 |
Daunomycin |
198 |
>500 |
5 |
|
TA 100 |
2-Aminoanthracene |
326 |
>500 |
5 |
Sodium azide |
274 |
>500 |
5 |
|
TA 1535 |
2-Aminoanthracene |
67 |
>300 |
5 |
Sodium azide |
83 |
>300 |
5 |
|
TA 1537 |
2-Aminoanthracene |
107 |
210 |
2 |
ICR 191 Acridine |
126 |
283 |
2 |
|
WP2 uvrA |
2-Aminoanthracene |
251 |
407 |
4 |
4-Nitroquinoline-1-oxide |
756 |
1532 |
4 |
N: number of studies
Table 1: Test result - Micronucleus assay (in vitro)
Test item |
Concentration (µg/mL) |
Threshold value* (3-fold of negative control) |
Number of cells with micronuclei (%) |
Exposure period 4 h, fixation time 24 h, without S9-mix |
|||
Vehicle |
0 |
1.35 |
0.45 |
Colchicine |
0.2 |
1.85 |
|
Test item |
0.178 |
1.15 |
|
0.53 |
0.55 |
||
1.6 |
0.65 |
||
Exposure period 4 h, fixation time 24 h, with 2% (v/v) S9-mix |
|||
Vehicle |
0 |
1.95 |
0.65 |
Benzo(a)pyrene |
5 |
2.7 |
|
Test item |
0.178 |
1.15 |
|
0.53 |
0.8 |
||
1.6 |
1.2 |
||
Exposure period 24 h, fixation time 24 h, without S9-mix |
|||
Vehicle |
0 |
1.35 |
0.45 |
Colchicine |
0.2 |
4.3 |
|
Test item |
0.178 |
0.6 |
|
0.53 |
0.85 |
||
1.6 |
0.9 |
*: A 3-fold increasing of micronuclei in comparison with the average of negative controls was set as threshold value.
Table 1: Results of the preliminary cytotoxicity/solubility test
Test concentration (µg/mL) |
CE 1 |
CE 2 |
||
without S9-mix |
with S9-mix |
without S9-mix |
with S9-mix |
|
Test I |
||||
0.32 |
0.65 |
0.71 |
1.01 |
0.92 |
1.6 |
0.57 |
0.87 |
0.68 |
0.56 |
8 |
0.73 |
0.56 |
0.85 |
0.69 |
40 |
0.70 |
0.89 |
0.69 |
0.85 |
200 |
0.87 |
1.12 |
0.66 |
0.84 |
1000 |
0.26 |
0.43 |
0.76 |
0.67 |
5000 |
0.12 |
0.28 |
0.47 |
0.53 |
Test II |
||||
125 |
1.09 |
0.94 |
1.03 |
0.97 |
250 |
0.57 |
0.56 |
1.04 |
0.87 |
500 |
0.29 |
0.28 |
0.64 |
0.85 |
1000 |
0.23 |
0.21 |
0.94 |
0.73 |
2000 |
0.20 |
0.18 |
0.86 |
0.77 |
Table 2: Results of the Main test and Confirmatory Test (CE 1 and CE 2)
Test concentration (µg/mL) |
CE 1 |
CE 2 |
||
without S9-mix |
with S9-mix |
without S9-mix |
with S9-mix |
|
Main Test |
||||
Vehicle |
0.93 |
0.86 |
0.84 |
1.00 |
31.25 |
1.00 |
0.88 |
0.85 |
0.98 |
62.5 |
0.95 |
0.65 |
0.80 |
0.88 |
125 |
0.83 |
0.57 |
0.79 |
1.03 |
250 |
0.73 |
0.67 |
0.94 |
0.92 |
MMS |
0.87 |
- |
0.58 |
- |
BaP |
- |
0.68 |
- |
0.92 |
Confirmatory Test |
||||
Vehicle |
0.96 |
1.42 |
0.77 |
0.94 |
31.25 |
0.71 |
1.05 |
0.92 |
1.01 |
62.5 |
0.73 |
1.07 |
1.14 |
0.87 |
125 |
0.76 |
1.22 |
0.99 |
0.82 |
250 |
0.71 |
0.86 |
1.17 |
0.89 |
MMS |
0.71 |
- |
0.66 |
- |
BaP |
- |
0.88 |
- |
0.91 |
MMS: methylmethanesulfonate
BaP: benzo(a)pyrene
Table 3: Results of the Main test and Confirmatory Test (MF)
Test concentration (µg/mL) |
MF |
|||
Big colonies |
Small colonies |
|||
without S9-mix |
with S9-mix |
without S9-mix |
with S9-mix |
|
Main Test |
||||
Vehicle |
67.18 |
98.16 |
60.25 |
72.66 |
31.25 |
51.50 |
95.96 |
78.48 |
102.05 |
62.5 |
59.00 |
91.35 |
65.22 |
75.93 |
125 |
69.20 |
63.61 |
62.44 |
62.33 |
250 |
69.14 |
65.80 |
55.79 |
62.62 |
MMS |
297.67 |
- |
1087.05 |
- |
BaP |
- |
290.25 |
- |
683.79 |
Confirmatory Test |
||||
Vehicle |
106.21 |
106.05 |
70.15 |
56.92 |
31.25 |
59.95 |
113.08 |
39.60 |
61.40 |
62.5 |
80.52 |
97.70 |
54.92 |
48.39 |
125 |
97.70 |
112.44 |
48.39 |
51.77 |
250 |
71.24 |
115.04 |
51.13 |
60.37 |
MMS |
363.50 |
- |
1757.64 |
- |
BaP |
- |
289.87 |
- |
730.98 |
MMS: methylmethanesulfonate
BaP: benzo(a)pyrene
Table 4: Historical control data (CE 1, CE 2 and MF)
Controls |
CE 1 |
CE 2 |
||||||||
MIN |
MAX |
MEAN |
SD |
N |
MIN |
MAX |
MEAN |
SD |
N |
|
Medium (-S9-mix) |
0.88 |
1.25 |
0.84 |
0.15 |
5 |
0.90 |
1.22 |
0.86 |
0.17 |
5 |
Medium (+S9-mix) |
0.87 |
1.05 |
0.87 |
0.09 |
5 |
0.93 |
1.24 |
0.85 |
0.16 |
5 |
MMS (-S9-mix) |
0.63 |
1.01 |
1.04 |
0.14 |
5 |
0.61 |
1.08 |
1.16 |
0.27 |
5 |
BaP (+S9-mix) |
0.80 |
1.00 |
0.99 |
0.13 |
5 |
0.73 |
1.12 |
1.06 |
0.11 |
5 |
MMS: methylmethanesulfonate
BaP: benzo(a)pyrene
SD: standard deviation
N: number of studies
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Genetic toxicity (mutagenicity) in bacteria in vitro
A reliable bacterial gene mutation study (Ames Test) performed according to OECD TG 471 and in compliance with GLP is available with boron orthophosphate (CAS 13308-51-5) (Kolp, 2015a). The Salmonella typhimurium tester strains TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvrA were tested according to the pre-incubation (experiment I) and plate incorporation (experiment II) procedure in the absence and presence of a metabolic activation system (Aroclor 1254-induced rat liver S9-mix (10% (v/v))). Two independent experiments were conducted in the concentration range from 313 to 5000 µg/plate (experiment I and II). No relevant cytotoxicity was observed in a preliminary toxicity test performed with tester strains TA 98 and TA 1535 after treatment with the test item up to 5000 µg/plate in the absence and presence of metabolic activation. Slight precipitation was seen in all test material concentrations which did not influence the results of the assay. Appropriate solvent (distilled water) and positive controls were included and gave the expected results. No significant increase in the number of revertants was observed in any of the tester strains with and without metabolic activation. Therefore, the test material was considered to be non-mutagenic under the conditions of the test.
Genetic toxicity (cytogenicity) in mammalian cells in vitro
An in vitro Micronucleus Test equivalent or similar to OECD TG 487 and in compliance with GLP was performed with boron orthophosphate (CAS 13308-51-5) (Prietzsch, 2015). Chinese hamster lung fibroblasts (V79) were treated in duplicate cultures with the test material or vehicle (RPMI 1640 medium supplemented with 10% (v/v) FBS) in the absence or presence of a metabolic activation system (Aroclor 1254-induced rat liver S9-mix 2% (v/v)). Short-term (4 hours with and without S9 mix) and long-term (24 hours without S9 mix) experiments were conducted at concentrations of 0.178, 0.53 and 1.6 µg/mL. Fixation of the cells was performed 24 hours (approx. 1.5 to 2.0 normal cell cycles) after start of exposure with the test material. Appropriate solvent and positive controls were included in the test and gave the expected results. The number of micronucleated cells found after treatment with the test item was within the normal range of the negative control and thus no genotoxic effects were recorded either in the presence or in the absence of metabolic activation. No cytotoxicity was determined either in a preliminary cytotoxicity test or within the main experiments, thus dose selection for the main experiment is questionable. Only slight cytotoxicity (19.8%) and precipitation were reported at the highest test concentration of 1.6 µg/mL without any details given. Nevertheless, based on the results of the study the test material is considered not to be clastogenic under the conditions of this in vitro study.
Genetic toxicity (mutagenicity) in mammalian cells in vitro
An in vitro Mammalian Cell Gene Mutation Test was performed with boron orthophosphate (CAS 13308-51-5) in mouse lymphoma L5178Y cells (heterozygous at the thymidine kinase locus) equivalent or similar to OECD TG 476 and under GLP (Kolp, 2015b). The cells were treated with the test substance in duplicate cultures, together with vehicle (RPMI 1640 medium supplemented with 10% (v/v) heat inactivated horse serum) and positive controls (single cultures). The cells were exposed to the test substance for 3 hours in the absence and presence of metabolic activation (Aroclor-1254-induced rat liver S9-mix (1% (v/v)) in the main and the confirmatory test. The concentration range of the test material in both experiments was 31.25 to 250 µg/mL following the results of a preliminary toxicity test. Slight precipitations were seen in all test material concentrations which did not influence the results of the assay. The vehicle controls (RPMI 1640 medium supplemented with 10% (v/v) heat inactivated horse serum) were within the normal range for the L5178Y cell line at the TK locus. The positive controls induced marked increases in the mutant frequency indicating the satisfactory performance of the test and of the activity of the metabolising system. No cytotoxicity was determined within the main experiments. Moreover, no vehicle controls were used in a preliminary cytotoxicity tests, thus dose selection for the main experiment is considered to be questionable. Nevertheless, the test material did not induce any toxicologically significant increases in the mutant frequency at any concentration level up to and including 250 μg/mL. The distribution of small and big colonies showed neither chromosome nor gene mutations. Thus, the test material was considered to be non-mutagenic to L5178Y cells under the conditions of the test.
Conclusion
Taken together, the available data on genetic toxicity with boron orthophosphate (CAS 13308-51-5) do not indicate any mutagenic and clastogenic potential. Thus, the test substance is not to be classified.
Justification for classification or non-classification
The available data on genetic toxicity with boron orthophosphate (CAS 13308-51-5) do not meet the criteria for classification according to Regulation (EC) No 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.